A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer.
- DOI
- 10.1007/s00280-009-1230-3
- Published
- 2010 Oct
- Container
- Cancer chemotherapy and pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-009-1230-3,
title = {A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer.},
author = {Sehouli J and Camara O and Mahner S and Bauknecht T and Lichtenegger W and Runnebaum I and Look K and Jaenicke F and Oskay-Oezcelik G},
year = {2010},
journal = {Cancer chemotherapy and pharmacology},
doi = {10.1007/s00280-009-1230-3},
url = {https://doi.org/10.1007/s00280-009-1230-3}
}RIS
TY - JOUR TI - A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer. AU - Sehouli J AU - Camara O AU - Mahner S AU - Bauknecht T AU - Lichtenegger W AU - Runnebaum I AU - Look K AU - Jaenicke F AU - Oskay-Oezcelik G PY - 2010 JO - Cancer chemotherapy and pharmacology DO - 10.1007/s00280-009-1230-3 UR - https://doi.org/10.1007/s00280-009-1230-3 ER -
APA
J, S., O, C., S, M., T, B., W, L., I, R., K, L., F, J., & G, O. (2010). A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-009-1230-3
Source records
- pubmed · retrieved 2026-09-26T00:11:11.175Z